Advertisement
Singapore markets open in 6 hours 14 minutes
  • Straits Times Index

    3,314.05
    +0.57 (+0.02%)
     
  • S&P 500

    5,313.39
    +10.12 (+0.19%)
     
  • Dow

    39,868.17
    -135.42 (-0.34%)
     
  • Nasdaq

    16,799.69
    +113.72 (+0.68%)
     
  • Bitcoin USD

    68,712.71
    +2,113.05 (+3.17%)
     
  • CMC Crypto 200

    1,424.89
    +70.47 (+5.36%)
     
  • FTSE 100

    8,424.20
    +3.94 (+0.05%)
     
  • Gold

    2,440.80
    +23.40 (+0.97%)
     
  • Crude Oil

    79.81
    -0.25 (-0.31%)
     
  • 10-Yr Bond

    4.4340
    +0.0140 (+0.32%)
     
  • Nikkei

    39,069.68
    +282.30 (+0.73%)
     
  • Hang Seng

    19,636.22
    +82.61 (+0.42%)
     
  • FTSE Bursa Malaysia

    1,627.50
    +10.88 (+0.67%)
     
  • Jakarta Composite Index

    7,266.69
    -50.55 (-0.69%)
     
  • PSE Index

    6,682.78
    +64.09 (+0.97%)
     

mDR Full Year 2023 Earnings: S$0.049 loss per share (vs S$0.011 profit in FY 2022)

mDR (SGX:Y3D) Full Year 2023 Results

Key Financial Results

  • Revenue: S$215.6m (up 23% from FY 2022).

  • Net loss: S$42.5m (down from S$9.22m profit in FY 2022).

  • S$0.049 loss per share (down from S$0.011 profit in FY 2022).

revenue-and-expenses-breakdown
revenue-and-expenses-breakdown

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Distribution Management Solutions (DMS) segment contributing a total revenue of S$173.7m (81% of total revenue). Notably, cost of sales worth S$183.2m amounted to 85% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling S$47.4m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how Y3D's revenue and expenses shape its earnings.

ADVERTISEMENT

mDR shares are down 4.0% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for mDR you should be aware of, and 1 of them can't be ignored.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.